Skip to content

Latest News

Biocon Biologics inks pact with Sandoz for sale of 2 biosimilar products in Australia

Biocon Biologics inks pact with Sandoz for sale of 2 biosimilar products in Australia

The agreement provides Sandoz the exclusive rights to promote, sell and distribute biosimilars Trastuzumab and Bevacizumab in Australia, Biocon Biologics said in a statement. Read More ​ The agreement provides Sandoz the exclusive rights to promote, sell and distribute biosimilars Trastuzumab… Read More »Biocon Biologics inks pact with Sandoz for sale of 2 biosimilar products in Australia

en_USEnglish